The Rise of Specialty Ophthalmic Drugs in North America: Market Outlook for 2026-2034
North America continues to lead the advancement of ophthalmic healthcare due to its rising burden of eye diseases, expanding elderly population, and increasing focus on preventive vision care. The region benefits from robust healthcare systems, continuous pharmaceutical innovation, and widespread adoption of advanced ophthalmic therapies and drug delivery technologies. Growing investments in...
0 Commentaires 0 Parts 9 Vue 0 Aperçu